The success of these medicines has spurred development of next-generation GLP-1-based drugs, promising greater weight loss, improved tolerability and additional options for the route and frequency of dosing
As fat mass decreases, some stored vitamin D may be released, but this does not guarantee adequacy
Based on epidemiological data, chronic hyperglycemia in poorly controlled patients with T2D is thought to have a cancer-promoting proliferative effect (reviewed in Ref
Modeling research published in PMC shows that modest weight loss reduces annual healthcare spending by approximately 15% per person, with effects rising in patients with higher baseline BMI and more comorbidities
eClinicalMedicine , 69 , 102475
The original plan: BALANCE would launch in Medicare Part D in January 2027, and the Bridge would cover the gap between July 2026 and that launch